D. Papamichael

4.7k total citations · 1 hit paper
26 papers, 3.7k citations indexed

About

D. Papamichael is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, D. Papamichael has authored 26 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in D. Papamichael's work include Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (5 papers) and Gastric Cancer Management and Outcomes (5 papers). D. Papamichael is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (5 papers) and Gastric Cancer Management and Outcomes (5 papers). D. Papamichael collaborates with scholars based in United Kingdom, Greece and France. D. Papamichael's co-authors include Michel Seymour, Aimery de Gramont, Filippo de Braud, Jim Cassidy, F. Morvan, Christophe Louvet, Arié Figer, H. Cortés-Funes, Abdel Hmissi and N Le Bail and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

D. Papamichael

26 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer

2000 3.0k citations Aimery de Gramont, Arié Figer et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Papamichael United Kingdom	15	3.0k	958	916	817	567	26	3.7k
M. Homerin France	10	2.9k 0.9×	883 0.9×	944 1.0×	884 1.1×	423 0.7×	17	3.5k
C. Wilson Canada	6	2.7k 0.9×	822 0.9×	899 1.0×	729 0.9×	419 0.7×	9	3.2k
Daniel Hendler Israel	7	2.7k 0.9×	824 0.9×	899 1.0×	685 0.8×	407 0.7×	19	3.2k
Tsai‐Shen Yang Taiwan	11	2.8k 0.9×	1.1k 1.2×	1.3k 1.5×	579 0.7×	588 1.0×	19	3.7k
N Le Bail France	12	4.7k 1.6×	1.4k 1.4×	1.5k 1.6×	1.1k 1.4×	718 1.3×	23	5.5k
May Alakl France	5	2.4k 0.8×	722 0.8×	847 0.9×	543 0.7×	354 0.6×	8	2.9k
Élisabeth Carola France	17	2.2k 0.7×	852 0.9×	680 0.7×	415 0.5×	338 0.6×	58	2.5k
Philip R. Clingan Australia	17	4.7k 1.5×	1.4k 1.5×	617 0.7×	1.3k 1.6×	1.1k 2.0×	45	5.6k
R.D. James United Kingdom	27	2.9k 1.0×	1.6k 1.7×	484 0.5×	2.2k 2.7×	617 1.1×	58	4.5k
J. L. Misset France	27	2.1k 0.7×	1.0k 1.1×	419 0.5×	452 0.6×	438 0.8×	63	3.0k

Countries citing papers authored by D. Papamichael

Since Specialization

Citations

This map shows the geographic impact of D. Papamichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Papamichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Papamichael more than expected).

Fields of papers citing papers by D. Papamichael

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Papamichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Papamichael. The network helps show where D. Papamichael may publish in the future.

Co-authorship network of co-authors of D. Papamichael

This figure shows the co-authorship network connecting the top 25 collaborators of D. Papamichael. A scholar is included among the top collaborators of D. Papamichael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Papamichael. D. Papamichael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loh, Kah Poh, Gábor Liposits, Sankalp Arora, et al.. (2024). Adequate assessment yields appropriate care—the role of geriatric assessment and management in older adults with cancer: a position paper from the ESMO/SIOG Cancer in the Elderly Working Group. ESMO Open. 9(8). 103657–103657. 19 indexed citations

Baldini, Capucine, Étienne Brain, Siri Rostoft, et al.. (2021). 1827P European Society for Medical Oncology (ESMO)/International Society of Geriatric Oncology (SIOG) Joint Working Group (WG) survey on management of older patients with cancer. Annals of Oncology. 32. S1237–S1238. 3 indexed citations

Biganzoli, Laura, Stuart M. Lichtman, D. Papamichael, et al.. (2015). Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG). European Journal of Cancer. 51(17). 2491–2500. 20 indexed citations

Kountourakis, Panteleimon, et al.. (2012). Barrett's esophagus: treatment or observation of a major precursor factor of esophageal cancer?. PubMed. 16(3). 425–30. 3 indexed citations

Gaafar, Rabab, Veerle Surmont, Giorgio V. Scagliotti, et al.. (2010). A double-blind, randomized, placebo-controlled phase III intergroup study of gefitinib (G) in patients (pts) with advanced NSCLC, non-progressing after first-line platinum-based chemotherapy (EORTC 08021-ILCP 01/03).. Journal of Clinical Oncology. 28(15_suppl). 7518–7518. 33 indexed citations

Papamichael, D., Riccardo A. Audisio, Bengt Glimelius, et al.. (2008). Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Annals of Oncology. 20(1). 5–16. 134 indexed citations

Papamichael, D.. (2008). Challenges in treating older cancer patients: colon cancer. Annals of Oncology. 19. vii104–vii108. 4 indexed citations

Razis, E., Evangelos Briasoulis, Ioannis V. Kostopoulos, et al.. (2006). Predictive markers for the treatment of colorectal cancer with cetuximab. Journal of Clinical Oncology. 24(18_suppl). 13500–13500. 1 indexed citations

Björkholm, Magnus, Emma Johansson, D. Papamichael, et al.. (2003). Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution study. Seminars in Oncology. 30(2). 226–230. 33 indexed citations

10.

Bamias, Aristotle, D. Papamichael, K. Syrigos, & Nicholas Pavlidis. (2003). Phase II Study of Irinotecan and Mitomycin C in 5-Fluorouracil-Pretreated Patients with Advanced Colorectal and Gastric Cancer. Journal of Chemotherapy. 15(3). 275–281. 14 indexed citations

11.

Mulatero, C, et al.. (2001). A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma. Lung Cancer. 31(1). 67–72. 26 indexed citations

12.

Gramont, Aimery de, Arié Figer, Michel Seymour, et al.. (2000). Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer. Journal of Clinical Oncology. 18(16). 2938–2947. 3040 indexed citations breakdown →

13.

Seymour, Michel, et al.. (1999). Epirubicin, cisplatin and oral UFTwith leucovorin (‘ECU’): A phase I–II study in patients with advanced upper gastrointestinal tract cancer. Annals of Oncology. 10(11). 1329–1333. 10 indexed citations

14.

Slevin, M L & D. Papamichael. (1998). Is there a standard adjuvant treatment for colon cancer?. European Journal of Cancer. 34(11). 1652–1655. 6 indexed citations

15.

O’Byrne, Kenneth J., D. Papamichael, H Robertshaw, et al.. (1998). A randomised, concentration-controlled, comparison of standard (5-day) vs. prolonged (15-day) infusions of etoposide phosphate in small-cell lung cancer. Annals of Oncology. 9(11). 1205–1211. 16 indexed citations

16.

Foran, James M., John Apostolidis, D. Papamichael, et al.. (1998). High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre. Annals of Oncology. 9(8). 865–869. 67 indexed citations

17.

Papamichael, D., et al.. (1997). Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter. British Journal of Cancer. 75(4). 606–607. 94 indexed citations

18.

Papamichael, D., et al.. (1996). Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor. Annals of Hematology. 73(6). 259–263. 8 indexed citations

19.

Ellis, Peter, Kenneth J. O’Byrne, D. Papamichael, et al.. (1996). Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer.. Journal of Clinical Oncology. 14(6). 1903–1912. 26 indexed citations

20.

Papamichael, D., et al.. (1976). Bone mass in thalassaemic children. Calcified Tissue International. 22(S1). 407–411. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact